You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 18, 2024

GLENMARK PHARMS LTD Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS LTD, and what generic and branded alternatives to GLENMARK PHARMS LTD drugs are available?

GLENMARK PHARMS LTD has one hundred and forty-three approved drugs.

There are eight tentative approvals on GLENMARK PHARMS LTD drugs.

Summary for GLENMARK PHARMS LTD

US Patents:	0
Tradenames:	117
Ingredients:	108
NDAs:	143

Drugs and US Patents for GLENMARK PHARMS LTD

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glenmark Pharms Ltd	SEVELAMER HYDROCHLORIDE	sevelamer hydrochloride	TABLET;ORAL	204724-001	Feb 8, 2019	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Glenmark Pharms Ltd	OLMESARTAN MEDOXOMIL	olmesartan medoxomil	TABLET;ORAL	203281-001	May 25, 2017	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Glenmark Pharms Ltd	ALCLOMETASONE DIPROPIONATE	alclometasone dipropionate	CREAM;TOPICAL	079061-001	Jun 23, 2009	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Glenmark Pharms Ltd	TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE	trandolapril; verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	079135-002	May 26, 2010		RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for GLENMARK PHARMS LTD drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.